The previous alert contains incorrect stock prices. A corrected version follows. We apologize for the error.
Human Genome Sciences (HGSI) announced Thursday morning that it has received an unsolicited proposal from GlaxoSmithKline (GSK) to acquire HGS for $13.00 per share in cash. The HGS Board of Directors has determined that the offer does not reflect the value inherent in HGS.
Human Genome Sciences has gapped open dramatically higher Thursday and is now up 7.15 at $14.32 on above average volume. The stock has surged to a 6-month high and has re-crossed both its 50 and 200-day moving averages.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.